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Abstract
This integrative review provides a comparative view of cognitive behavioral therapy
(CBT) and pharmacotherapy (PCT) as treatment modalities for adult depression. The
foci of this integrative review are to examine research articles on CBT and PCT to
determine which therapy, monotherapy or combination therapy, provide a higher level of
therapy for depression. The metrics utilized are depression symptom remission, response
to therapy, recovery from depression, and quality of life. Individual preference and
response to treatment vary. This makes the reader more aware that specific populations
may be more receptive to one therapy instead of the other.
Keywords: Cognitive behavior therapy, pharmacotherapy, and comparative, best
treatment modality, depression in adults
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Comparative look at the Depression Treatment Modalities of Cognitive
Behavioral Therapy and Pharmacotherapy
Depression is a major public health concern with a sobering economic impact of
billions of dollars per year (CDC, 2015). The increase in incidence continues to climb,
adding more stress to the national health care budget. Supported by the research of
Angstman, Rasmussen, Herman, and Sobolik (2011), the likelihood of a person being the
victim of depression in a lifetime have a prevalence rate of about 17 percent. According
to the National Institute of Mental Health there are an estimated 15.7 million adults, 18 or
older, who suffer at least one major episode of depression a year (NIMH, 2009). This
alarming number of depression diagnoses continues to climb. Not only is depression a
mental health concern it also impairs physical function. Depression, anxiety, and
substance abuse are often comorbid conditions with a diagnosis of chronic depression.
These have a high correlation with medical illness, social, and interpersonal relationship
problems. Depression often leads to maladaptive cognitive processing which can cause
decreased job performance exhibited by absenteeism, decreased performance, and poor
productivity (Angstman et al., 2011).
Alarming facts on how depression impacts health care economy and patient care
outcomes fuel the desire for more effective depression therapies. The treatment
modalities of pharmacotherapy (PCT) and cognitive behavior therapy (CBT) are the two
most commonly utilized treatment modalities for adult depression. The person that feels
sad, lonely, and hopeless can be offered depression treatment modalities by their primary
care provider (PCP). Consistency in medical management and collaborative care has
shown to decrease long term health care costs. However, short term costs have shown an
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increase due to more collaborative integration of PCPs, psychiatrists, and health care
managers (Angstman, et al., 2011). The health care arena of today focuses more on
health wellness and promotion than tertiary treatment. Research shows that medical
management of chronic health problems, such as depression, will decrease health care
costs and improve patient care outcomes (Angstman, et al., 2011; Kilbourne, Williams,
Bauer, & Arean, 2012; NICE, 2015).
Depression is one of the most underdiagnosed mental health illness in primary
care (USPSTF, 2016), and exhibits a distinctive phenomenology, due to the changes in
neurobiological, physiological, psychological, and social dynamics. The significance of
mental health is a principal concern for PCPs and is echoed by the Commission on
Mental Health. Gaps in treatment and the importance on mental health are addressed in
the statement “the implementation gap prevents our nation from reaping the benefit of
billions of United States tax dollars spent on research and, more important, prolongs the
suffering of millions of Americans who live with mental disorders” (Kilbourne et al.,
2012, p.1).
The World Health Organization (WHO) ranks depression as the fourth leading
cause of global burden of disease and it is expected to be the second cause of global
burden of disease by 2020 (Gyani, Pumphrey, Parker, Shafran, & Rose, 2012). Despite
attempts at depression treatment strategies, patient inconsistency, and nonadherence to
treatment impede success. Successful depression treatment is evidenced by restoration of
functioning and quality of life, not just symptom management (Lam & Kennedy, 2015).
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Depression is a broad spectrum diagnosis and exhibits many behavioral changes.
The economic burden of the uninsured, and society’s negative association of a
depression, diagnoses, steer many depressed people away from seeking treatment.
Depression is marked by changes in mood and declining participation in pleasurable
activities. Diagnosis is determined by the gross screening of the following two questions:
(a) During the past month have you often been bothered by feeling down, depressed, or
hopeless? (b) During the past month have you experienced little interest or pleasure in
doing things? (NICE, 2015). The National Institute for Health and Care Excellence
(NICE, 2015) provide algorithms, pathways, and frameworks to increase knowledge and
guidance, for PCPs, in depression management.
There are three levels of depression; mild, moderate, and severe. The majority,
70 percent, of depression is categorized as mild. According to NICE in 2007 the
estimated incidence of depression ranged from three to six percent of the nation’s
population. The spectrum of treatment therapy ranged from CBT to hospitalization for
management of depression. People requiring treatment for depression are predicted to
increase by 17 percent, 1.45 million people, by 2026 (NICE, 2015). Standards of care for
the depressed population are described by NICE as high quality and cost-effective
collaborative care that improves the safety and effectiveness of treatment (NICE, 2015).
Guidelines for depression, provided by NICE, do not specify which treatment
modality, CBT or PCT, offer the best results for complete remission and restoration of
functioning and quality of life. In this integrative review on CBT and PCT, existing
research studies were analyzed for comparisons in the treatment of symptoms, obtaining

4

remission, and the restoration in quality of life. Indecision remains, among PCPs, as to
which is the most effective depression treatment modality, CBT or PCT (Lam &
Kennedy, 2015; Sinyor, Schaffer & Levitt, 2010).
Cognitive behavioral therapy and PCT, for the treatment of adult depression, vary
by many techniques. The most significant variation is the ability to keep the person in
remission and maintain functioning and improved quality of life. The Sequenced
Treatment Alternative to Relieve Depression Trial (STAR*D) was a large scale trial
funded by the United States. National Institute of Mental Health (Sinyor et al., 2010).
This trial examined treatment options for patients refractory to antidepressant therapy.
This trial had four levels: consisting of (a) monotherapy of an antidepressant medication;
(b) medication switching to another medication or CBT; (c) medications augmented with
CBT; and (d) medication changing with other medications. The trial allowed a
collaborative decision to be made in determining which treatment option the patient
received. The four level trial was designed to mimic real-life situations. In real-life
situations the patient is the center of therapy and has a choice in their therapy modality.
Limitations of this trial was allowing the multiple treatment modalities to impede
sample size. This produced groups too small for meaningful and clinical differences
between treatments (Lam & Kennedy, 2015). One error in the trial was that CBT was
never tested alone. The advantage of CBT was fewer side effects and patients remained
in remission longer than with PCT (Sinyor et al., 2010). This trial did bring into question
if different treatment modalities would work better or more effectively in particular
patient populations?
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Pharmacotherapy was shown to be more effective initially in moderate to severe
depression. Pharmacotherapy alone can help with symptom reduction. However,
remission and return to a productive, quality life is less likely in the patient with severe,
multiple depressive episodes (Sinyor et al., 2010). Combination therapy was recognized
as effective in some patient populations. Pharmacotherapy helped the depressive
symptoms to subside earlier and CBT helped the patient obtain and stay in remission
which allowed the patient to regain productivity and improved quality of life. Evaluation
measurements were obtained with the utilization of the Hamilton Depression Rating
Scale (HDRS) and the Quick Inventory of Depression Symptomology- Self-Report (Lam
& Kennedy, 2015). Measurement-based care provided the tools needed to help evaluate
and augment the effectiveness of the depression treatment modality being utilize.
Supporting Framework
Consumer- centered collaborative care of depression was utilized for patient care
management. The primary purpose of this project was to evaluate CBT and PCT for best
adherence, symptom management, symptom remission and restoration of a quality life.
The Consumer-Centered Collaborative Care of Depression (McCusker, Yaffe, Sussman,
Kates, Mulvale, Jayabarathan…….Haggerty, 2012) was the framework that provided
guidance for the project. This framework considers the patient to be the center of care
and focuses on meeting health care needs while collaboratively working with the patient
and family.
Morgan & Yoder (2012) considered the defining attributes of the PersonCentered- Care concept to (a) maintain a holistic approach, (b) individualize care, (c) at

6

all times be respectful, and (d) empower the patient to own and manage self-depression,
with supporting resources. The single and most impacting influence of this framework
was “the philosophy of putting the relationship before the task when planning care”
(Morgan & Yoder, 2012, p.10). McCusker et al. (2012) devised and prioritized a list of
eight attributes that were the most important for a cohesive working arrangement among
the primary care provider, family and patient. These attributes, in order, are (1)
respectfulness; (2) involvement of consumer in treatment decisions; (3) accessibility; (4)
provision of information; (5) system coordination; (6) whole-person care; (7)
responsiveness to changing needs; and (8) comprehensiveness.
Problem Statement
Depression is the number one mental health disorder and is often undiagnosed.
The vast majority of depression is treated in primary care. Treatment for depression
requires consistency and a sound evidenced based foundation (Gyani, et al., 2012).
Statistical data to support the significance of a succinct depression treatment protocol can
be seen in all age ranges as reported by the Center for Disease Control (CDC, 2015). The
Guide to Clinical Preventive Services offer recommendations by the United States
Preventive Services Task Force (USPSTF, 2016) for primary care settings. The most
prominent recommendation, for depression treatment, is to utilize depression screening
tools in conjunction with preventive services (CDC, 2015). The United States Preventive
Services Task Force acknowledges most health care providers are the gatekeepers to
interventions and recommendations.
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The United States Preventive Services Task Force and Clinical Guide provide
three recommendations for all providers. These recommendations include (a)
reinforcement of health care provider’s advisement; (b) identify of the most effective
community-based and health–care programs that will offer education and other
supportive interventions; and (c) identification of supportive services for the patient
population (CDC, 2015). These guidelines should be utilized in the management and
treatment of one of the top ten chronic diseases, depression. Cognitive behavioral
therapy and PCT are listed as the two top depression treatment and management
modalities. The phenomenon of uncertainty between these two depression treatment
modalities needs further evaluation.
Depression is not limited to any single age and is seen throughout all aspects of
socioeconomics (CDC, 2015). The CDC found from 2007 to 2010, in any two week
period, eight percent of persons, 12 years of age and older, were diagnosed with
depression (CDC, 2015). Eight million patients were seen nationwide with the diagnosis
of depression from 2009-2010. These patients were seen in hospitals, outpatient clinics,
physician offices, and emergency rooms. This number continues to escalate as
depression remains the number one mental illness. Major depressive disorders were seen
as first-line diagnosis in hospital discharges from 2009-2010. The discharge diagnose of
depression alone were estimated to be around 395,000 (CDC, 2015).
Health care costs continue to escalate while there remains limited mental health
services to the high risk population (USPSTF, 2016). The average length of hospital time
for a major depression episode is six and one half days. Often the high risk population
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are uninsured or lack mental health coverage. This equals lost hospital revenue and
compounds health care issues (CDC, 2015). Mental health is crucial to overall health.
Often outpatient clinics, counseling services, support groups, or primary care services are
unavailable or unsuccessful with depression management (CDC, 2015). This only adds
to an already overwhelmed health care system.
Purpose of the Project
The purpose of this integrative review was to review current literature on the
difference between CBT and PCT treatment modalities of depression in the adult
population. Differences that were looked at were symptom management, remission and
quality of life (QOL). Follow up care was seen as a vital part, for patient management,
after referral or during current treatment. Patients can get lost in the system thus
impacting quality and continuity of care. The prudent practitioner maintains close
follow-up parameters to stay in touch with the patient and monitor treatment progress
(Zaccagnini, & White, 2014). Additional resources for continuity of care utilize best
practice standards, as well as ongoing educational programs and management of chronic
diseases (NICE, 2015).
The overall consideration of this integrative review was a systematic evaluation to
help determine which is more effective, CBT or PCT, in achieving remission and
improvement in QOL? The population focused on is the 18 to 65 year old, depressed
aggregate. The two depression treatment and management modalities focused on were
CBT and PCT, these are supported by NICE guidelines for depression treatment as the
most frequently recommended and utilized (Clark, 2011).
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Research Goals and Objectives
This integrative review specifically addressed clinical outcomes of the depressed
adult population as result of treatment with CBT or PCT.
The goals of this project:
1. To provide a systematic review of research comparing the depression treatment
modalities of CBT and PCT
2. To provide a review of research that will present evidence as to which treatment
modality, CBT or PCT, help the depressed person reach symptom remission.
3. To provide a review of research that will present evidence as to which treatment
modality, CBT or PCT, help the depressed person improve QOL.
The initial literature review was completed utilizing the support of Harris Copper’s
(1982) Scientific Guidelines for Conduction Integrative Research Reviews. This
conceptual framework allowed for a systematic organized manner to process data. Three
research strategies where utilized in obtaining specific primary data on CBT and PCT.
Methods
Study Design
The underpinning of literature reduction was obtained by categorizing and coding
by specific criteria. Types of studies were reduced to meta-analysis, meta-analysis and
systematic reviews of randomized controlled trials, clinical guidelines based on
systematic reviews, randomized controlled trials, and non-randomized control trial Prior
to this step particular topics were reduced to searchable themes.. The phenomena
reviewed were depression treatment modalities of CBT and PCT which were coded as
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such. The literature search was on the population of depressed adults, 18 to 65 years old,
and restricted any co-morbid conditions. This was the preliminary criteria for data
collection. Whittemore and Knafl’s (2005) rational for data reduction followed this
statement; “succinct organization of the literature facilitates the ability to systematically
compare primary sources on specific issues, variable, or sample characteristics” (p. 550).
Data was extracted from primary sources and displayed in a matrix table (se
Appendix A for the literature matrix). This was in alphabetical order according to the
author’s name. This process enhanced visualization and maintained an organized chart.
Patterns and relationship of literature were displayed to assist in carefully analyzing the
data. The matrix provided an organized manner to systematically categorize each
research journal article utilized in this integrative review. A graph containing all data on
utilized articles provided a second means of validation (see Figure 1 for the table of
evidence).
The data comparison stage further examined and compared the themes,
categories, similarities, differences, key components and grouping. A concept map
revealed the main idea of depression treatment modality and surrounding variables. The
data presentation matrix allowed for visualization of accurate and meaningful
comparisons, relevant theme, similarities, patterns, and differences.
The depression treatment modalities of CBT and PCT focused on symptom relief,
remission, and quality of life. Findings became apparent from analyzing 23 research
studies which treatment modality offered the best patient outcomes. Trials favoring
treatment with CBT alone contained one hundred fifty-five trials and had better symptom

11

relief, remission, improved quality of life, and had enduring effects from the therapy.
One hundred thirty-one trials showed equal patient treatment response with
pharmacotherapy alone or with CBT alone. One hundred thirty trials responded more
favorably to the treatment of combination therapy. Two trials presented results that
showed PCT providing better patient outcomes in the depressed adult population without
depression relapses. (see Appendix A for the literature matrix).
Four meta-analysis contained 155 trials revealing data that CBT had a higher
depression remission rate than combination therapy or PCT alone. Two random control
trials represented data confirming CBT to be the superior treatment modality for
depression. Combination therapy was supported by three meta-analysis containing 106
trials that showed remission of depression symptoms, 36 trials addressed quality of life
(QOL) and one control trial addressed remission and recovery
Equal treatment outcomes with cognitive behavioral therapy alone or PCT alone.
was supported by 131 trials. In these trial there were six meta-analysis that consisted of
128 trials, 56 trials with data to support remission alone, and 72 trials showing response
and remission to treatment. This project revealed two random control trials supporting
PCT as the superior treatment. One trial showed response and remission and the other
trial only addressed remission.
Problem Formulation
An integrative review demands rigor and high standards. To maintain this
rigorous standard, extensive training was completed with the Collaborative Institutional
Training Initiative ([CITI], see Appendix C CITI training certificate). This integrative
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review was driven by the need to disclose the best treatment modality for the adult
depressed population. The mental health population deserves the least invasive, cost
conscious, effective treatment for depression. This integrative review utilized the robust
methodology of Cooper (1998) and Whittemore and Knafl (2005). Following this
methodology maintained rigor and decreased bias. Following procedure, an application
was presented to the institutional review board (IRB). There were no human subjects or
contact with medical records in this paper. However, for sake of rigor and experience,
this process was followed.
Data Collection
Data collection and literature review were held to stringent analysis. This
procedure helped maintain proper coverage of the phenomena of depression and
treatment modalities of CBT and PCT Cooper (1982) and Whittemore & Knafl (2005)
both agree there are two goals for data collection: (a)“findings that pertain to all previous
research on the problem, and (b) findings that allow for generalization to the unit of
analysis that interests the topic area” (Cooper, 1982, p. 294-295). A comprehensive
review of literature was performed on the CBT and PCT. Inclusion and exclusion criteria
contained the age limit of 18-65, only English full text peer review journal articles, and
date restriction of 2009-2016 (see Table 1 for the inclusion and exclusion criteria).
Data were retrieved from seven databases and multiple data retrieval techniques
were utilized A comprehensive search strategy included a computer-assisted search of
the Cochrane Library, Pub Med, Medline, National Guideline Clearinghouse, Cumulative
Index of Nursing and Allied Health Literature (CINAHL), Researchgate and Elton B.
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Stephens Co. host. (EBSCO) Data retrieval was restriction by the inclusion and exclusion
criteria. A review of the literature was analyzed for topic specific data. Key words and
phrases that were used for search included: cognitive behavior therapy,
pharmacotherapy, comparative, best treatment modality, depression, and adults.
Research articles were obtained and placed in topic specific reservoirs. Further exclusion
criteria included age, comorbid conditions, and limited to full text articles written in
English. The compilation of data was examined and placed in the matrix (see Appendix
A for the literature matrix). There were two key areas to consider when assessing
validity.
The retrieved studies were obtained and assessed utilizing the inclusion and
exclusion criteria. Reviews were examined for differences and similarities. The
realization that all the reviews did not contain all pertinent topics of interest were a
factor in data collection. To protect validity and minimize biased research, as many
sources as possible were reviewed. Acknowledging the possibility of missed or
overrepresented samples are mentioned as a possible impact on the findings (Cooper,
1998). The population of focus was adults with the primary diagnosis of depression and
without comorbid conditions. Cognitive behavioral therapy and PCT were looked at
individually and comparatively, and assessed for management of depression symptoms,
remission rates and QOL.
Levels of evidence were established utilizing the valid tool Melnyk Pyramid
(2011). Melnyk Pyramid has seven levels of evidence, each one with specific criteria.
Level one has the highest level and maintains strict adherence to “systematic review and
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meta-analysis of randomized controlled trials; clinical guidelines based on systematic
reviews or meta-analysis” (Melnyk & Fineout-Overholt, 2011, p.1). Melnyk Pyramid
(2011) provided an algorithm to assist in identifying each level of evidence. These
validated levels added rigor and authenticity to this study. In this integrative review the
levels of evidence according to Melnyk ranged from level one to level three. Level one
had 13 articles, level two had nine articles, and level three had one article
Data Evaluation
Data evaluation is a critical part of relevant research. Points were assigned to
specific research data criteria. Studies were reviewed with these points in mind. Data
with too many irrelevant factors were excluded. Evaluating data for this integrated
review was complex especially since this process utilized qualitative, quantitative and
governmental standards as metrics. The quality of these resources were evaluated for
authenticity, quality, informal value, and methodology. The mixed-method methodology
provided diversity making this integrative review unique with a broad spectrum view to
assess new approaches to the phenomena of depression treatment (Whittemore & Knafl,
2005).
Cooper (1982) and Whittemore & Knafl (2005) models were utilized as the
conceptual frameworks for format organization of this integrative review. Cooper’s
(1982) conceptualized model for an integrative review contained five stages: (a) problem
formulation; (b) data collection; (c) evaluation of data points; (d) data analysis and
interpretation; and (e) presentation of results. Whittemore & Knafl (2005) provided a
similar format to Cooper (1982). However, the data analysis stage was more elaborate
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and further delineated the differences in data reduction, data display, data comparison,
conclusion drawing and verification. These additional steps enhanced the rigor of this
process.
Instructions to guide an integrative review were provided in an articles by
Whittemore & Knafl (2005) An integrative review was defined by Whittemore & Knafl
(2005) as “a specific review method that summarizes past empirical or theoretical
literature to provide a more comprehensive understanding of a particular phenomenon or
health care problem” (p. 546). An integrative review involves interdisciplinary
collaboration to bring to light a new paradigm of a phenomena in original research. The
systematic rigorous method of research, collection, analysis, and presenting outcomes,
added to the scholarly standard of the original research (Cooper, 1982; Moran et al.,
2014; Whittemore & Knafl, 2005). Moran et al. (2014) support the scholarly approach to
an integrative review as “a serious, discipline work that seeks to interpret, draw together,
and bring new insight to bare on original research” (p. 64).
The PRISMA checklist provided established guidelines to follow for evaluation of
qualitative and quantitative data. Both, Cooper (1982) and PRISMA defined criteria of
an integrative review to:
Identify an appropriate topic or issue for the review, justify why a literature
review is an appropriate means of addressing the topic or problem, search and
retrieve the appropriate literature, analyze and critique the literature, and create
new understanding of the topic through one or more forms of synthesis. (Torraco,
2005, p. 356-357)
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These models added rigor and provided guidance throughout this integrative
review. The step by step sequencing provided details for data collection and additional
resources provided guidelines for critiquing (Coughlin & Cronin, 2007; Ryan, 2009). An
important step in problem formation was to identify the conceptual and operational
variables. PRISMA and Cooper (1982) share an intricate design that was mimicked and
specific parameters were maintained. These parameters utilized the five stages of
structure to provide further rigor. The PRISMA model added further structure to the
review. and the step by step instructions of PRIMSA provided the specifications needed
to ensure the precision of this scholarly prepared project.
Variable inclusion and exclusion pertain to the significance of data being too
narrow or too broad (Whittemore & Knafl, 2005). This procedure helped define which
variables were relevant and which were irrelevant. The significance of the foundational
work impacted the reviews validity. “Narrow concepts might make review conclusions
less definitive and robust. Superficial operational details might obscure interacting
variables” (Cooper, 1982, p. 293). Cooper (1998) stated primary research begins with
specific well defined parameters and integrative reviews begin with an idea or loose
comparisons and become well defined as EBP research prevails. This integrative review
followed this idea for project formulation.
Data Analysis
The data analysis of this integrative review used specific word codes for inclusion
and exclusion of literature (see Table 1 for inclusion and exclusion criteria). Cooper
(1982) inferred that integrative reviews were not obligated to apply the typical standard
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analysis, therefore a coding system was introduced to provide rigor to this review.
Whittemore & Knafl (2005) recommended the use of codes, categories, summarization of
integrated conclusions about the research. Research and literature were categorized into
types of studies for this review. Inclusion and exclusion tables provided a concrete
means of evaluating variables. Methods that were utilized to analyze data for this review
were supported by Whittemore & Knafl (2005). “A constant comparison method is one
overarching approach used in a broad array of qualitative design that converts extracted
data into systematic categories, facilitating the distinction of patterns, themes, variations,
and relationships” (Whittemore & Knafl, 2005, p. 530). This method assisted in the
synchronization of data for this review.
Levels of evidence were supported with the utilization of the Melnyk Pyramid
(2011), which has seven levels of evidence, each one with specific criteria. Level one
had the highest level and maintains strict adherence to “systematic review and metaanalysis of randomized controlled trials; clinical guidelines based on systematic reviews
or meta-analysis” (2011, p.1). Melnyk Pyramid (2011) further assisted the reviewer,
with an algorithm for each level of evidence. These validated levels added rigor and
authenticity to this study. In this review validation ranged from level one the level three,
eleven level one, and twelve level two, and one level three study.
Data reduction. The underpinning of literature reduction was obtained by
categorizing and coding specific criteria. Types of studies were reduced to meta-analysis,
systematic reviews of randomized controlled trials, clinical guidelines based on
systematic reviews, randomized controlled trials, and non-randomized control trial. Prior
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to this step, particular topics were reduced to searchable themes. Depression was the
phenomena reviewed with the treatment modalities of CBT and PCT. The search criteria
reduced the number of articles for review to 23. Additional filtering criteria was
population of depression to adults 18 to 65 years old and restricted any co-morbid
conditions. Whittemore and Knafl’s (2005) rational for data reduction followed this
statement; “succinct organization of the literature facilitates the ability to systematically
compare primary sources on specific issues, variable, or sample characteristics” (p. 550).
Data display. Data was extracted from primary sources and displayed in a matrix
table (see Appendix A for the literature matrix) and displayed in alphabetical order
according to the author’s last name. This process enhanced visualization and maintained
organization. Patterns and relationship of literature were displayed to assist in carefully
analyzing data. The matrix provided an organized manner to systematically categorize
each research journal article in this integrative review. A graph containing all the data
provided a second means of verification (see Figure 1 for the table of evidence).
Data comparison. The data comparison stage further examined and compared
the themes, categories, similarities, differences, and identified key components and
groups. A concept map revealed the main idea of depression treatment modality and
surrounding variables. The data presentation matrix allowed visualization of accurate
and meaningful comparison patterns. These comparisons revealed themes, similarities
and differences that made this integrative review a valid source of informative on the
depression treatment modalities of CBT and PCT
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Conclusion drawing and verification. Caution was exercised in this area to
avoid biased conclusions of data analysis. Whittemore & Knafl (2005) pointed out the
importance of avoiding premature closing options that can conclude research:
Explicit care needs to be undertake during this process to avoid premature
analytic closure (being locked into a particular pattern) or exclusion of pertinent
evidence. Addressing conflicting evidence is a considerable challenge,
particularly when results are equally compelling and from high quality reports.
(p.551)
Subgroups were categorized into four groups; CBT alone, PCT alone, combination, and
no difference in treatment. Trials were separated by categories of 13 meta-analysis, nine
randomized control trials, and one control trial. This integrative review consisted of
51,068 subjects and 418 trials. Patient response to CBT, PCT, combination and no
difference in treatment outcomes were assessed by specific criteria. The evaluation
criteria revealed symptom responses in 10 studies, 16 studies with remission, two studies
with recovery, and three studies revealed the patient QOL was impacted. The results of
trial numbers and participation response are as follows: CBT was represented by 155
trials, no difference was represented by 131 trials, combination therapy had 130
supportive trials, and PCT had two supportive trials.
Presentation
This integrated review maintained rigor and an extensive research of the topic.
Careful attention was devoted to data collection, assessment, and analysis to not omit or
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embellish data. The methodology was clear and concise, each step could easily be
reproduced to capture the same information presented in the original integrative review.
The PRISMA model provided an evidenced based set of items, in the forms of a flow
diagram and checklist. These tools assisted in maintaining rigor and validity. These
tools provided transparency to the data collection and display.
Tables and flow charts provided fluency in the data presentation and offered
reproducible methodology. Presentation of data in this format provided transparency and
instilled a trustworthy aspect to the review data. Data presented with as much detail as
possible, in a format that was easily interpreted, decreased the chances of unintentional
bias of data (see Appendix A for the literature matrix and Figure 1 for the table of
evidence).
This integrative review allowed unconventional data presentation and therefore,
afforded the research community the opportunity to fashion additional concepts
previously not considered. Utilizing this method may help bridge the gap in areas
otherwise thought to be closed. Whittemore and Knafl (2005) and Cooper (1982) gave
caution to combining dissimilar data due to the complexity of assimilation. However,
Whittemore & Knafl (2005) encouraged methodology whereas mixed method literature
and qualitative research had potential to decrease bias and error. Maximum effort was
extended to present unbiased material. This integrative review contained qualitative as
well as quantitative research studies. Levels of evidence utilized Melnyk Pyramid
(2011), which has seven levels of evidence, each one with specific criteria. Each journal
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article was subjected to the rigor of this pyramid and assigned levels of evidence. All the
articles had high levels of accuracy and validity.
Evaluation Methods
This integrative review received on-going evaluation, by the researcher, to
maintain rigor and a non-biased evaluation of the existing literature on depression
treatment modalities of CBT and PCT. The topics of CBT, PCT, depression treatment,
adult depression, opposition treatment, were searched through specific research data
bases These databases were utilized in the literature search for this integrative review:
computer-assisted search of the Cochrane Library, Pub Med, Medline, National
Guideline Clearinghouse, Cumulative Index of Nursing and Allied Health Literature
(CINAHL), Researchgate and Elton B. Stephens Co. (EBSCO) from 2009 to 2016.
A comprehensive research yielded 76,504 articles and an additional 20 from
references of other research studies. Resources were screened for duplicates, and
inclusion and exclusion criteria. Research studies remaining that met eligibility criteria
were 127. After further evaluation of these articles for comparisons within the age range
and without comorbidities, the remaining studies left for data collections were 23 peer
review articles. These 23 articles were placed in a matrix for transparency and
organization. The matrix was alphabetized by the journal author’s name. Included in the
matrix was type of study, number of subjects, number of trials, and the metrics of
response, remission, recovery, and QOL. Each article was categorized by supporting
treatment; CBT, PCT, combination, and no difference. Depression tools utilized for
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obtaining metrics were the Hamilton Rating Scale for Depression (HRSD) and
Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV).
The final 23articles were further sorted by levels of evidence utilizing the Melnyk
model. Once these were sorted, each article was analyzed for research design. These
yielded an overall total design of 13 meta-analysis, one control trial, and nine randomized
control trials. These 23 articles presented with significantly high levels of evidence.
Melnyk Pyramid of Levels of Evidence followed strict guidelines for leveling evidence.
The following three levels were represented in this integrative review: 12 level one, nine
level two, and one level three study. The Melnyk Model defined the levels as follows:
Level one is a systematic review & meta-analysis of randomized controlled trial; clinical
guidelines based on systematic reviews or meta-analysis, Level two represented one or
more randomized controlled trials, and level 3 represents controlled trial (nonrandomized), (Melnyk & Fineout-Overfelt, 2011).
Articles were selected and thoroughly evaluated by the PRISMA model, to meet
all the specific and limited criteria. The articles were categorized by supporting topics
which were CBT, PCT, combination and no difference. The metrics utilized were
symptom remission, response, recovery, and quality of life. Included in this review were
51,068 patients, and 418 trials. Methods of reliability relied on the reputation and
validity of the PRISMA model and Melnyk levels of evidence.
Results
This integrative review added to the existing body of knowledge on depression
treatment modalities of CBT and PCT, in the adult population. The research categories
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that were utilized for consistent treatment therapy and matrix grouping were CBT alone,
PCT alone, combination therapy, and, no difference between the therapies. A thorough
evaluation of literature is represented in this review
Cognitive Behavioral Therapy. Cognitive behavioral therapy proved to be the
best treatment option found in this integrative review. Out of the original 23 articles five
articles found CBT superior to treatment as usual (TAU) which consist of PCT. One
hundred fifty-five trials consisting of four meta-analysis and one randomized control trial
supplied data to support CBT for depression is more effective than PCT (Bockting et al.,
2015; Cuijpers et al., 2014; Cuijpers et al., 2013; Karyotaki et al., 2016; Linde et al.,
2015).
The 14,958 subjects in these trials showed significant treatment outcomes
utilizing CBT. The subjects presented with symptom relief, and showed enduring effects
with longer periods of time between depression episodes. Cognitive behavioral therapy
proved to have lasting effects even if the sessions were only during the acute phase of
depression. Individual biological and neurological make-up affect each person’s
response to treatment. Therefore, a closer look at personalized therapy development
which could impact patient cost and depression outcomes (Bockting et al., 2015;
Cuijpers, et al., 2012; Cuijpers, et al., 2013; Driessen, et al., 2016; Hegerl et al., IsHak et
al., 2011; 2010; Karyotaki et al., 2016; Quilty et al., 2014; Roshanaei-Moghaddam et al.,
2011; Sinyor et al., 2010; & Weitz et al., 2015).
Cognitive behavioral therapy offers two benefits not found with PCT. Research
showed that increased episodes of depression presents with resistance against the effects

24

of medication or PCT (Bockting et al., 2015). Therefore, it is not an option to continue to
increase and change PCT. However, this is what is often seen in current practice.
Another factor that impacts patient compliance and response to therapy is attitudes
toward antidepressant medications. There are patient populations that prefer
nonpharmacological options to treat depression (Linde et al., 2015). CBT is a viable, cost
effective alternative.
Metrics that were consistent throughout all the studies, to assess depression and
responses, were DSM-IV and the Hamilton Rating Scale for Depression (HRSD).
Additional metric tools utilized in some of the studies were Beck Depression InventoryFast Screen (BDI-FS), Dysfunctional Attitude Scale (DAS), Montgomery Asburg
Depression Rating Scale (MADRS), Trimbo’s/IMTA Self Report Questionnaire for Costs
Associated with Psychiatric Illness (TIC-P), and Structured Clinical Interview for DMSIV, DAS).
No Difference. A selective groups of research articles were analyzed to gather
evidenced based research (EBR) on the most effective depression treatment modality
between CBT and PCT. Cognitive behavioral therapy and PCT were the two top
depression treatment therapies recognized by the National Institute for Health and Care
Excellence (NICE, 2015). Selected research was analyzed revealing 131trials that
showed CBT alone or PCT alone provided the same patient treatment outcomes
(Cuijpers et al., 2012; Cuijpers et al., 2015; Cuijpers et al., 2013; Cuijpers et al., 2010;
Gartlehner et al., 2016; Hegerl et al., 2010; Henkel et al., 2010; Roshanaei-Moghaddam
et al., 2011; Quilty et al., 2014, Weitz et al, 2015).
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Cognitive behavioral therapy and PCT have specific individualized
characteristics. When treating adult depression, therapies needed to be assessed for
personalized therapy (Bockting et al., 2015; Cuijpers, et al., 2012; Cuijpers, et al., 2013;
Driessen, et al., 2016; Hegerl et al., IsHak et al., 2011; 2010; Karyotaki et al., 2016;
Quilty et al., 2014; Roshanaei-Moghaddam et al., 2011; Sinyor et al., 2010; Weitz et al.,
2015). Pharmacological therapy proved to be more effective in dysthymia patients, at
least in short-term treatment. In older adults, these two treatment modalities revealed no
difference in treatment. Special attention should always be paid to the benefits of
individual assessment when prescribing treatment as usual ([TAU], Cuijpers et al., 2012).
There was a discrepancy in study outcomes with blinded and non-blinded control
trials. Cuijpers et al. (2015) discovered that in non-blinded trials PCT was superior in
depression treatment and in blinded trials there was no significant difference between
treatment with CBT or PCT. The difference in the outcomes of these two forms of trials
brought to the forefront the importance of awareness in trial procedures and outcomes.
Depression treatments that showed no difference in patient outcomes had several
mechanisms of action. Negative cognitive structure changed more rapidly with CBT and
cognitive processing and depression severity changed more quickly with PCT. Both
treatment modalities impacted patient depression outcomes equally but utilized different
mechanisms of action (Quilty et al. 2014).
One of the most significant difference that CBT offers and PCT does not offer, is
the long-acting effect on patient remission. In multiple trials CBT presented with lower
relapse rates and prolonged effects regardless of number of sessions. Remission and
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QOL were a major emphasis on depression management (Bockting et al., 2015; Cuijpers
et al., 2013; Cuijpers et al., 2014; Karyotaki et al., 2016; Lam & Kennedy, 2015; Linde
et al., 2015; Sinyor, Schaffer & Levitt, 2010).
Assessment tools utilized in all categories of this integrative review were the
DSM-IV and HDRS. Additional tools utilized in the trials that showed no difference in
treatment were: BDI, Inventory for Symptomology Score (IDSS), Psychological Distance
Scaling Task (PDST), Research Diagnostic Criteria (RDC), Redundancy Card Sorting
Task (RCST), Self-referent Encoding Task (SRET), and Well Being Index (WBI) and
QOL.
Combination. Combination therapy with CBT and PCT, was the treatment
modality with the third highest study numbers, 130 trials. Since CBT was the most
researched psychological therapy, this type of behavioral therapy was utilized in all
categories of this integrative review. Pharmacological therapy varied and presented no
specific medication to utilize in this review.
Most combination trials looked at CBT and PCT separately and then in
combination. Each of the 130 trials in this category researched CBT alone and PCT
alone and assisted in identifying which therapy provided the best treatment outcomes.
Cognitive behavioral therapy and PCT were then compared to combination therapy.
Combination therapy was superior over monotherapy. Even though monotherapy
subjects showed improvement the level and speed of improvement increase with the
combination of CBT and PCT. Improvement in patient status impacted cost,
effectiveness and patient well-being. Often the depressed population is out of work or
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produce poorer work outcomes. Some may even be hospitalized. All scenarios impact
the depressed person’s ability to function in a productive manner and QOL. One
particular pattern continued to present in all the categories of this integrative review.
Long-term effects, remission, and increased time between relapses, presented in all trials
in which CBT was a factor (Cuijpers et al., 2013; Cuijpers et al., 2012; Cuijpers et al.,
2010; Hollon et al., 2014; IsHak et al., 2011; Wiles et al., 2013; Sinyor et al., 2010).
The combination therapy trials utilized both therapies in different sequences.
Some of the patterns initiated PCT first, and then added CBT. Pharmacotherapy and
CBT were combined at the same time, or PCT was discontinued, and BCT continued
with sessions approximately every month. These were some of the sequenced patterns
that were utilized. However, PCT and CBT were used in combination for a significant
time to gather the specific data needed to adequately evaluate treatment pattern results.
All the articles analyzed in this integrative review utilized the DSM-IV and HDRS to
measure depression, response, remission, recovery and QOL. Evidence from the
combination therapy study, revealed one trial response from combination therapy, five
trials exhibited remission, one trial presented with recovery, and three trials revealed
QOL impact.
Additional tools were utilized to obtain further detailed data. The additional
universal depression measurement validation tools were: BDI, Berlin Quality of Life
Profile (BQOLP), and Clinical Global Impression-Severity Scale (CGI-SS),
Dysfunctional Attitude Scale (DAS), DMS-IV, MADRS, 36 Item Short Form Health
Survey (SF-36), EuroQol EQ-5D Scale (Q-ES-Q/Q-LES-Q-SF), Quality of Life in
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Depression Scale (QLDS), Social Adjustment Scale-Self-Report (SAS-SR), +Quality of
Wellbeing (QWB), and World Health Organization Quality of Life Assessment
Instrument (WHOQOL-100 & WHO-QOL-BREF).
The trials evaluating combination research had high reliability based on the
Melnyk levels of evidence pyramid (2011). There were three level one studies, three level
two studies, and one level three. These studies contain 130 trials with 8116 subjects. This
category made particular reference to, CBT and PCT monotherapy effectiveness. However,
the overall research revealed that combination therapy was better than the monotherapy
and impacted QOL, whereas the other categories had very little impact on QOL. (Cuijpers
et al., 2013;Cuijpers et al., 2012; Cuijpers et al., 2010; Hollon et al,, 2014; IsHak et al,,
2011; Kohler et al., 2013; Wiles et al. , 2013; & Sinyor et al., 2010).
Pharmacotherapy. Pharmacotherapy had the fewest response therapy outcomes
in this integrative review. Pharmacotherapy offered a faster treatment response than
CBT. Kocsis et al. (2012) go as far as to make reference that first line monotherapy
with PCT, is contradicted by the national guidelines set by NICE (2015). Currently,
NICE (2015) recommends sociological management and CBT as first line therapy for
depression.
Antidepressant medications have a broad spectrum of therapies; anti-anxiolytics
to antipsychotics. Pharmacotherapy options may appear to be a quick fix and easier to
manage than some of the other therapies within the CBT family. Medication can be
obtained on sliding scale income fees at some clinics and pharmacies. Some drug
companies will offer free medication if finances are preventing the patient from obtaining

29

the drug. Once PCT treatment begins an assessment of symptoms and medication
adjustment takes place every three to four weeks. Medication can be increased or titrated
down, as the patient’s condition warrants. This allows the patient some control over the
treatment regimen. There are times when this may impact the patient’s treatment
response by giving the patient a sense of control. (Parker et al., 2013; Kocsis et al., 2009).
No medication is without side effects. Changes and titrations, in medications,
may be made to help achieve the correct medication and dose. Patients presenting with
first-time depression generally remain on medication for one year after symptom
remission. Patients presenting with a second depression episode warrants two years on
medication after symptom remission. Patients presenting with a third episode of
depression or never achieving remission will remain on medication for life (Alexopoulos
et al., 2001).
For continuity in metrics the same two depression assessment tools are
represented in all the research articles. Some the articles have additional assessment tools
but the two tools that were in all the studies were DSM-IV and HDRS. The PCT
category contained two trials, 20,645 subjects, and one trial provided data for symptom
response with PCT, and in two trials the subjects reached remission. Note, that each trial
may have achieved more than one measurement of validity.
Discussion
During the data review of scholarly articles on CBT and PCT for adult depression,
four key categories became apparent. This integrative review began by looking only at
the comparison between CBT alone and PCT alone. However, it became apparent that
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there were other options present in a large portion of research on this topic. Taking this
into account, an extensive data search and analysis was performed. This integrative
review expanded the original depression treatment option comparison to include: CBT
alone, PCT alone, no difference in treatment with CBT verses PCT, and treatment with
combination of CBT and PCT.
From the literature utilized in this review, the largest number of research trials
showed CBT demonstrated the best therapeutic patient outcomes, remission, and
enduring effects for long term efficacy. The second largest display of trials revealed no
difference in treatment with CBT or PCT. These therapies presented with response and
remission of depression. The third largest presentation of trials revealed that combination
therapy with CBT and PCT presented the best treatment results. The fourth and final
category of depression treatment was PCT, which contained two trials.
At the conclusion of the research for this integrative review an analysis of
research presented a gap. There did not appear to be any literature that categorized adult
depression treatments into the four categories as seen in this integrative review. Recent
research literature was presenting evidence that specific patient populations may respond
better to one therapy verse the other. Personalized therapy is a therapy that is now
becoming a topic of research. There were multiple research articles in this integrative
review that made reference to individualized medicine (Bockting et al., 2015; Cuijpers, et
al., 2012; Cuijpers, et al., 2013; Driessen, et al., 2016; Hegerl et al., IsHak et al., 2011;
2010; Karyotaki et al., 2016; Quilty et al., 2014; Roshanaei-Moghaddam et al., 2011;
Sinyor et al., 2010; Weitz et al., 2015).
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More research is needed to determine if patient demographics or characteristics
play an important role in individual response to different depression treatment modalities.
Exploration of individualized medicine would prevent the trial and error approach to
treatment. Individualized medicine could be cost effective and more therapeutic in
assisting patients in symptom remission and QOL improvement. This integrative review
has limitations including limited studies, and unequal study numbers for each treatment
modality, only one reviewer, and limited treatment modalities.
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Table 1
Inclusion and Exclusion Criteria
Inclusion

Exclusion

Publication from 2009-2016

Publication prior 2009

Depression patients

Comorbid conditions

Age 18-65

Outside age range

No comorbid conditions

Cognitive behavioral therapy

Other forms of

Pharmacotherapy

depression treatment

US Journal in English

Foreign journals
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Appendix A
Literature Matrix
Cognitive Behavioral Therapy Depression Treatment
Elements and Core
Outcomes,
Focus of

Concepts of
Level of

Article,

Conclusions,
CBT; Goals:

Evidence
Author/year

And
Remission or
Recommendations
Quality of Life

Description of 10

II

 CBT stopped after

 CBT has long-term

year follow up on

depressive episode

preventive effects

recurrent

& this showed long

on reoccurrences

depression with

term effects

 At 10 years the

CBT, (Bockting et

 DSM-IV criteria

group with CBT

al., 2015)

 HRSD,TIC-

that had multiple

P,SCID-I, DAS
 Randomized
control trial
 172 patients
 Remission
 Personalized
medical approach

depression
episodes was still
better than the
group with PCT
 Increased episodes
of depression
increased
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 Long term effects
with CBT

Description of CBT

I

on enduring

 9 studies with 506
patients

resistance against
the effects of PCT

 No difference acute
care CBT and

effects superiority

 HAMD

pharm continuation

over PCT

 Definitions in

on remission

(Cuijpers et al.,
2013)

Description of CBT
on depression
remission,

I

article p.2

 CBT superior when

 Remission

compared to acute

 Enduring effects

care CBT and

continue after

acute PCT and

treatment with

stopped post

CBT

discharge

 92 studies, 6937
patients
 DBI, BDI-II,

recovery, and

HAM-D

improvement,

 Remission

(Cuijpers, 2014)

 CBT superior in
symptom treatment
and Remission
 Offers long term
effects
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Description of CBT

I

in combination

 23 randomized

 In acute phase

control trials

CBT is superior to

and monotherapy

 2184 patients

combined therapy

long term effects,

 Recovery > 26

 In long term CBT

(Karyotaki et al.,

consecutive weeks

is as effective as

2016)

without relapse

combination

 Depression rating

 Has long-term

scales by American

effects

Psychiatric
Association (p.146)
Description of CBT
effectiveness in

I

 Compared to PCT
and placebo

 CBT of less
resources may have

MDD, (Linde et

 CBT is effective

similar effects as

al., 2015)

 Less resource

more intensive

intensive

treatment

 More eclectic

 50% decrease on

rather than

depression score

dogmatic

 Depression

 30 studies

measurement tools:

 5,159 patients

HRSD, BDI-FS,

 Remission

MADRS
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 Offers options for
patients wishing to
pursue nonpharmalogical
treatment

Note: BDI-FS= Beck Depression Inventory Fast Screen, CBT= Cognitive Behavior
Therapy, DAS= Dysfunctional Attitude Scale, DSM-IV criteria, HRSD= Hamilton
Rating Scale for Depression, MADRS= Montgomery Asburg Depression Rating Scale,
MDD= Major Depressive Disorder, PCT=Pharmacotherapy, TIC-P= Trimbo’s /IMTA
Self Report Questionnaire for Costs Associated with Psychiatric Illness, SCID-I=
Structural Clinical Interview for DMS-IV, DAS,
Metrics: Patient participation=15,299, Trials=111, Remission=6, Recovery=1

45
COGNITIVE BEHAVIOR THERAPY VS PHARMACOTHERAPY

Pharmacotherapy Depression Treatment
Elements and Core
Focus of

Outcomes,
Level of

Concepts of CBT;

Evidence

Goals: Remission or

Article,

Conclusions, And

Author/year

Recommendations
Quality of Life

Description of PCT

II

 .Randomized

 18 participants

superiority to

 . 29 participants

received

CBT in 12 week

 .HAM-D, HES

antidepressants

blind randomized

 .Measured respond and  11 received CBT

study (Parker et

remission

al., 2013)

 Low NNT shows
superiority over CBT

 At 4 weeks
antidepressant group
had significant
improvement,

Description of
augmentation of
CBT and PCT to

II

 . The REVAMP trial
 .Randomized trial with
three phases

 Compare PCT to
pharm with longterm and acute CBT

nonresponse

 .808 patients

and compared to

chronic

 . HDRS, DSM-IV

pharm and short-term

depression,

 .Response and

CBT

remission
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(Kocsis et al.,
2009)

 Findings revealed no
significant
improvement with
the addition of CBT
to PCT

Note: CBT=Cognitive Behavior Therapy, HAM-D= Hamilton Rating Scale for
Depression, HES= Hamilton Exogenous Subscale, NNT=Numbers needed to treat,
PCT= Pharmacotherapy
Metrics: Patients=837, Trials=2, Remission=2
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Combination Depression Treatment; Pharmacotherapy and Cognitive Behavioral
Therapy
Elements and Core
Focus of
Level of

Concepts of CBT;

Evidence

Goals: Remission or

Outcomes, Conclusions,

Article,
And Recommendations

Author/year
Quality of Life
Description of

I

 Meta-analysis

 Study indicated no

 20 studies (compare

significant difference

in depression,

CBT to PCT show

in treatment between

(Cuijpers et al.,

no difference in

these 2 type of

2013)

treatment)

treatment

comparative therapy

 (115 overall studies,

 But in Combined

show combination

treatment is

best)

significantly more

 HDRS, BDI
 Response and
remission

effective
 Measures 2 of the
groups looked at in this
1 study

Description of

I

 Systematic review

combination PCT

 54 studies combined

and CBT, Separate,

 4734 participants

 29 studies comparing
PCT and combined

48
COGNITIVE BEHAVIOR THERAPY VS PHARMACOTHERAPY

 Combined therapy is  14 comparisons

and personalized
depression treatment

best for depressed

between CBT and

(Cuijpers et al.,

out patients and

combined

2012)

older people
 20 characteristics
were examined
 Measure of
remission

 No significant
difference between
treatment with CBT or
PCT
 In outpatient combined
therapy significantly
more effective

Description of

I

 Meta-analysis,

 No significant was

comparative look at

randomized

found between CBT

combination and

controlled trials

and PCT

PCT for adult
depression,

 16 studies, 852
patients

(Cuijpers et al.,

 HAMD, BDI,

2010)

 Response,
Remission

 413 patients CBT and
pharm combination
 439 patients
combination CBT and
placebo
 No findings to support
that PCT was any more
effective than CBT in
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more sever baseline
depression
Description of

II

combined CBT and

 Randomized clinical
trial

 Combined Enhanced
rate of recovery

pharm verses PCT

 452 adult patients

 Fewer dropouts

alone (Hollon et al.,

 3 University Clinics

 Fewer adverse events

2014)

involved
 HRSD, DMS-IV, LI
 Remission

 Experienced less time
in the MDD episode
 CBT: 50 minute
sessions Twice weekly
for 2 weeks, then
weekly after acute
 Then at least monthly
during continuation

Description of
combination, PCT,

I

 Review
 Screening scales SF-

 All treatments showed
some improvement but

or CBT( &

36, WHOQOL-100,

most significant is

psychotherapies) on

WHOQOL-BREF,

combined therapy

QOL with

EQ-5D, Q-ES-Q/Q-

 Combined showed

depression patients,

LES-Q-SF, QLDS,

(IsHak et al., 2011)

QWB, BQOLP,

greater reduction in
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CGI-SS, MADRS,

symptoms and

SAS-SR, HRSD

improved QOL

 36 studies

 Health focus is

 14,669 patients

changing from life

 7 studies

preserving to increased

psychotherapy alone

quality post

(608 pts)

intervention

 23 studies PCT
alone (12,225 pts)
 7 studies combined
therapy (1836 pts)
 Remission &
improved QOL
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Description of

III

 Controlled Trial

combination CBT

 206 patients

and PCT

 Screening tools:

effectiveness (Kohler
et al., 2013)

 .Preformed under
naturalistic conditions
 Response to Treatment

BDI, HAMD, DAS,

with PCT and CBT in-

CGI-SS, DSM-IV,

patient only (HAMD:

ICD-10

19.86, BDI: 11.36)

 Response, recovery
& remission

 Treatment with PCT
and CBT & additional
CBT post discharged
from hospital (HAMD:
22.21, BDI: 14.99)
 Remission: Inpatient
CBT and PCT
(HAMD: 51%, BDI:
43.1%)
 Remission: Inpatient
CBT in addition to post
discharge CBT and
PCT (HAMD: 72%,
BDI: 58.8%)
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Description of
combination in

II

 Randomized
control trial

treatment resistant

 Screening tools:

depression: CoBalt

BDI, ICD-10,

 Trial study on PCT, or
PCT and CBT
 Follow-up for 12
months

trial, (Wiles et al.,

 469 patients

2013)

 73 practices in UK

CBT and PCT are

 Response: 50%

effective at reducing

reduction in
depressive

 Robust findings that

depressive symptoms
 At end of study 46%

symptoms within 6

improved with PCT

months (BDI)

and CBT
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 Response &
improved QOL
Description of

II

 Largest randomized

 22% improved with
PCT alone
 4 levels; 1=PCT alone,

combination

trial done on CBT

2= augmentation to

depression

and PCT

pharm, 3=equipoise-

treatment, STAR*D,

 6 years study

stratified randomized

(Sinyor et al., 2010)

 Cost US $35

(pt choice),

million
 Remission, QOL
 2876 pts

4=randomized 2 PCT
 Not a true test between
PCT and CBT because
pt was always on PCT
even with CBT was
introduced
 CBT and PCT showed
significant
improvement than PCT
alone

Note: BDI= Beck Depression Inventory, BQOLP= Berlin Quality of Life Profile, CBT=
Cognitive Behavioral Therapy, CGI-SS= Clinical Global Impression- Severity Scale,
DAS=Dysfunctional Attitude Scale, DMS-IV= Diagnostic and Statistical Manual of
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Mental Disorders 4th edition, HRSD= Hamilton Rate Scale for Depression,
MADRS=Montgomery Asberg Depression Rating Scale, MDD= Major Depression
Disorder, pts= Patients, PCT=Pharmacotherapy, SF-36= 36 Item Short Form Health
Survey, Q-ES-Q/Q-LES-Q-SF=EuroQol EQ-5D Scale, QLDS= quality of Life in
Depression Scale, QOL= Quality of Life, SAS-SR= Social Adjustment Scale-SelfReport, QWB= Quality of Wellbeing, WHOQOL-100 & WHO-QOL-BREF= World
Health Organization Quality of Life Assessment Instrument, UK=United Kingdom,
Metrics: Patients=23,406, Trials=209, Remission=2, Response+remission=1,
Remission+QOL=1, Response+recovery+remission=1, Response+QOL=1,
Remission+QOL=1
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No Significant difference between Two Depression Treatment Modalities;
Pharmacotherapy or Cognitive Behavioral Therapy
Elements and Core
Focus of

Concepts of

Outcomes,

Level of
Article,

CBT; Goals:

Conclusions, And

Remission or

Recommendations

Evidence
Author/year

Quality of Life
Description of
combination PCT
and CBT,
Separate, and

I

 Systematic
review
 54 studies
combined

 29 studies
comparing PCT and
combined
 14 comparisons

personalized

 4734 participants

between CBT and

depression

 Combined

combined

treatment (Cuijpers

therapy is best for  No significant

et al., 2012)

depressed out

difference between

patients and older

treatment with CBT

people

or PCT

 20 characteristics
were examined
 Measure of
remission

 In outpatient
combined therapy
significantly more
effective
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Description of PCT

1

to CBT in blinded

 35 randomized
trials

study, (Cuijpers et

 3721patients

al., 2015)

 HAM-D-17
 Remission

 PCT superior to
CBT in non-blinded
study
 No significant
difference between
CBT and PCT in
blinded study-best
indication

Description of
comparative

I

 Meta-analysis
 20 studies

 Study indicated no
significant

therapy in

(compare CBT to

difference in

depression,

pharm show no

treatment between

(Cuijpers et al.,

difference in

these 2 type of

2013)

treatment)

treatment

 (115 overall

 But in Combined

studies, show

treatment is

combination best)

significantly more

 HDRS, BDI
 Response and
remission

effective
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 Measures 2 of the
groups looked at in
this 1 study
Description of

I

 Meta-analysis,

 No significant was

comparative look

randomized

found between CBT

at combination and

controlled trials

and PCT

 16 studies, 852

PCT for adult
depression,

patients

(Cuijpers et al.,

 HAMD, BDI,

2010)

 Response,
Remission

 413 patients CBT
and PCT
combination
 439 patients
combination CBT
and placebo
 No findings to
support that PCT
was any more
effective than CBT
in more sever
baseline depression

Description of
comparative harms
and benefits of

I

 An Evidence
Report for

 Moderate strength
evidence
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PCT, CBT,

Clinical Practice

complementary

Guideline

and exercise

 Response and

therapy in

remission

depression,

screening tools

(Gartlehner et al.,
2016)

 20 RCT in
22 .publications
with 3000
patients

 PCT and CBT led
similar rates in
response and
remission
 Guidelines from
American College
of Physicians
 Similar response
rates 8-16 weeks of

 Screening tools:

treatment with CBT

HAM-D, BDI,

& PCT (CBT=44%,

HDRS, RDC

pharm 46%)
 Similar Remission
rates (41%CBT to
48%PCT)
 2 trials showed
CBT had lower
relapse rates
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Description of

II

comparison PCT

 368 patients

 Reduction in HDRS

 Randomized,

virtually identical;

and CBT including

placebo-

patient’s arm,

controlled,

(Hegerl et al.,

single-center
 HDRS, IDSS,

2010)

WHO-5, DSMIV, QOL
 Response

PCT 6.8, CBT 6.7
 Scores show
significant
improvement in
QOL
 Patient Arm for
choice decision did
not impact outcome

Description of

II

 95 patients

comparison of

 HAMD

PCT and CBT in

 Post-hoc analysis

atypical

 Response

 Double blind and
single blind study
 10 week treatment
period
 Did not reveal any

depression,
(Henkel et al.,

difference between

2010)

CBT and PCT

Description of
combination
/comparison of CBT
and PCT in

I

 Meta-analysis,
randomized

 Similar effects with
both treatments

control

 Similar effects in

 21 studies

groups with and
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 2027 patients:

treatment of
anxiety and

1095 PCT, 932

depression,

CBT

(Roshanaei-

 HDRS

Moghaddam et al.,

 Response

without placebo
controls

2011)
Description of

II

 Randomized trial

 PCT showed earlier

cognitive structure

 104 patients

treatment response

and processing

 HAM-D, BDI-II,

with lower

during CBT vs.

PDST, RCST,

depression severity

PCT, (Quilty et al.,

SRET

by week 4

2014)

 Symptom
response

 CBT showed earlier
negative
interpersonal
content distance (in
week 8)
 Cognitive structure
and processing are
both impacted by
CBT and PCT
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Description of
baseline
depression
outcomes between

I

 Randomized

 794=CBT

clinical trials

 906=PCT

 DSM,HAM-D,

 CBT and PCT are

BDI

equal in response

CBT and PCT

 16 trial

and remission of

(Weitz et al., 2015)

 1700 out pts

baseline depression

 Response and
remission

Note: BDI-II=Beck Depression Inventory, IDSS=Inventory for Symptomology Score,
RCT= Random Control Trials, HDRS/HAM-D=Hamilton Depression Rating Scale,
PCT=Pharmacotherapy, PDST=Psychological Distance Scaling Task, RDC= Research
Diagnostic Criteria, RCST=Redundancy Card Sorting Task, SRET=Self-referent
Encoding Task, WHO-5=Well-being Index, QOL=Quality of Life
Metrics: Patients=11,867, Trials=116, Remission=1, Response=4,
Response +remission

62
COGNITIVE BEHAVIOR THERAPY VS PHARMACOTHERAPY

PRISMA 2009 Flow Diagram

Identification

Appendix B
Records identified through
database searching

Additional records identified
through other sources
(n =20)

(n= 76,504)
(n = )

Included

Eligibility

Screening

Records after duplicates removed
(n =76,204)

Records screened
(n= 76,204)

(n = )
Full-text articles assessed
for eligibility
(n =127)

Studies included in
quantitative synthesis
(meta-analysis)
(n =23)

Welch V, Petticrew M, Tugwell P, Moher D, O'Neill J, & Waters, E.
(2012) PRISMA-Equity 2012 Extension: Reporting Guidelines for
Systematic Reviews with a Focus on Health Equity. PLoS Med 9(10):
e1001333. doi:10.1371/journal.pmed.1001333

Records excluded
(n =76,077)

Full-text articles excluded,
with reasons
(n 104)
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Table of Evidence
Figure 1
Author/Year

Meta

C

RC

T

T

Bockting et al.

1

n= pts

n=

Res

Rem

Rec

QOL

Findings

trial
172

1

1

CBT

1

506

9

1

CBT

1

6937

92

1

CBT

1

2184

23

(2015)
Cuijpers et al.
(2013)
Cuijpers et al.
(2014)
Karyotaki et al.

1 w/o

(2016)

CBT

relaps
e

Linde et al.

1

5159

30

14,958

155

3721

35

1

CBT

(2015)
4
Cuijpers et al.

1

0

1

0

4

1

0

CBT Totals

1

0 Diff

(2015)
Cuijpers et al.

1

20

1

1

0 Diff

16

1

1

0 Diff

(2013)
Cuijpers et al.
(2010)

1

852
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Gartlehner et al.

1

3000

20

1

1

0 Diff

1

368

1

1

0 Diff

1

95

1

1

0 Diff

2027

21

1

0 Diff

104

1

1

0 Diff

1700

16

1

1

11,867

131

8

5

852

16

1

1

(2016)
Hegerl et al.
(2010)
Henkel et al.
(2010)
Roshanaei-

1

Moghaddam et
al. (2011)
Quilty et al.

1

(2014)
Weitz et al.

1

0 Diff

(2015)
6
Cuijpers et al.

0

3

1

0

0

0 Diff Total
Combine

(2010)
Cuijpers et al.

1

20

Combine

(2013)
Cuijpers et al.

1

4734

54

1

Combine

425

1

1

Combine

(2012)
Hollon et al.
(2014)

1
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IsHak et al.

1

14669

36

1

206

1

1

1

469

1

1

2876

1

3

8116

130

1

Combine

(2011)
Kohler et al.

1

1

Combine

(2013)
Wiles et al.

1

1

Combine

1

Combine

3

Combine

(2013)
Sinyor et al.

1

(2010)
3

1

1

5

1

Total
Parker et al.

1

29

1

1

20,616

1

1

PCT

1

1

PCT

(2013)
Kocsis et al.
(2009)

TOTALS

0

0

2

20,645

2

1

2

0

0

13

1

9

51,068

418

11

16

2

3

PCT Total

Note: Meta= mate-analysis, CT=Control trial, RCT= Randomized control trial, Pts=
patients, Res = Response, Rem = Remission, Rec =Recovery, QOL= Quality of life,
CBT=Cognitive behavioral therapy, PCT= Pharmacotherapy, Combine= Combination, 0
Diff= No difference
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Figure 2
IRB Email of Approval
Good Evening Terri,

Based on the federal regulations (45 CFR 46.102(f)), your study is not considered human subjects
research, so an approval letter is not warranted. I met with the Department of Nursing on March 9, and
they are aware of this aspect of the regulations and the possibility of their students receiving nonhuman subjects research letters from the IRB.

Best,

G. Michele Baker, MA, CIP
Administrative Chair of Institutional Research
The Graduate School
(434) 592-5530

Liberty University | Training Champions for Christ since 1971
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Appendix C
CITI Training
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